Novel diagnostic and predictive biomarkers in pancreatic adenocarcinoma
JC Chang, M Kundranda - International journal of molecular sciences, 2017 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease for a multitude of
reasons including very late diagnosis. This in part is due to the lack of understanding of the …
reasons including very late diagnosis. This in part is due to the lack of understanding of the …
[HTML][HTML] Usefulness of carbohydrate antigen 19-9 test in healthy people and necessity of medical follow-up in individuals with elevated carbohydrate antigen 19-9 …
SP Lee, IK Sung, JH Kim, SY Lee… - Korean Journal of …, 2019 - ncbi.nlm.nih.gov
Background Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker whose level is elevated
in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to …
in many types of cancers and other benign conditions. CA 19-9 levels are frequently found to …
[PDF][PDF] Neoadjuvant therapy and prognostic factors in pancreatic ductal adenocarcinoma
A Nurmi - 2021 - helda.helsinki.fi
Pancreatic cancer is one of the deadliest cancers, with a dismal 5-year overall survival rate
ranging from 2% to 8%. Pancreatic ductal adenocarcinoma (PDAC) represents> 90% of …
ranging from 2% to 8%. Pancreatic ductal adenocarcinoma (PDAC) represents> 90% of …
[PDF][PDF] Club bibliográfico SERAM Número 10/14.
SA Germán - cbseram.com
El artículo que voy a revisar se trata de un estudio descriptivo retrospectivo en el que tras
una selección de pacientes de acuerdo a unos criterios clínicos establecidos se intenta …
una selección de pacientes de acuerdo a unos criterios clínicos establecidos se intenta …
人間ドック受診者における腫瘍マーカーCA19-9 高値例の検討
鈴木朋子， 今井瑞香， 窪田素子， 北嘉昭… - 人間ドック(Ningen …, 2015 - jstage.jst.go.jp
目的: 腫瘍マーカーは早期がんでは上昇しにくい, 偽陽性が多いなどの理由から,
スクリーニングには不適格と考えられている. 今回 CA19-9 について, 受診者への適切な情報提供 …
スクリーニングには不適格と考えられている. 今回 CA19-9 について, 受診者への適切な情報提供 …